BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2254446)

  • 1. Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase.
    Reed SL; Gigli I
    J Clin Invest; 1990 Dec; 86(6):1815-22. PubMed ID: 2254446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica.
    Reed SL; Curd JG; Gigli I; Gillin FD; Braude AI
    J Immunol; 1986 Mar; 136(6):2265-70. PubMed ID: 2869084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica.
    Reed SL; Keene WE; McKerrow JH; Gigli I
    J Immunol; 1989 Jul; 143(1):189-95. PubMed ID: 2543700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
    J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the alternative pathway of complement by Entamoeba histolytica.
    Ortiz-Ortiz L; Capin R; Capin NR; Sepúlveda B; Zamacona G
    Clin Exp Immunol; 1978 Oct; 34(1):10-8. PubMed ID: 219975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic model.
    Meléndez-López SG; Herdman S; Hirata K; Choi MH; Choe Y; Craik C; Caffrey CR; Hansell E; Chávez-Munguía B; Chen YT; Roush WR; McKerrow J; Eckmann L; Guo J; Stanley SL; Reed SL
    Eukaryot Cell; 2007 Jul; 6(7):1130-6. PubMed ID: 17513563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement resistance of pathogenic Entamoeba histolytica mediated by trypsin-sensitive surface component(s).
    Hamelmann C; Urban B; Foerster B; Horstmann RD
    Infect Immun; 1993 May; 61(5):1636-40. PubMed ID: 8478051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of pathogenic and nonpathogenic Entamoeba histolytica by human complement: methodological analysis.
    Hamelmann C; Foerster B; Burchard GD; Horstmann RD
    Parasite Immunol; 1992 Jan; 14(1):23-35. PubMed ID: 1557228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique cysteine proteinase gene of pathogenic Entamoeba histolytica correlates with virulence.
    Reed S; Bouvier J; Hirata K; Que X; Pollack AS; Engel JC; Gillin F; McKerrow JH
    Arch Med Res; 1992; 23(2):181-2. PubMed ID: 1340288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New concepts regarding the pathogenesis of amebiasis.
    Reed SL
    Clin Infect Dis; 1995 Oct; 21 Suppl 2():S182-5. PubMed ID: 8845450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanism of acquired resistance to complement-mediated lysis by Entamoeba histolytica.
    Gutiérrez-Kobeh L; Cabrera N; Pérez-Montfort R
    J Parasitol; 1997 Apr; 83(2):234-41. PubMed ID: 9105303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation by antigenic fractions of Entamoeba histolytica.
    Meri S; Richaud G; Linder E
    Parasite Immunol; 1985 Mar; 7(2):153-64. PubMed ID: 2860628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the alternative and classical complement pathways by Entamoeba histolytica.
    Calderon J; Schreiber RD
    Infect Immun; 1985 Nov; 50(2):560-5. PubMed ID: 2865212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunogenic 30-kDa surface antigen of pathogenic clinical isolates of Entamoeba histolytica.
    Blakely P; Sargeaunt PG; Reed SL
    J Infect Dis; 1990 Oct; 162(4):949-54. PubMed ID: 2205653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of the alternative complement pathway by various axenic strains of Entamoeba histolytica].
    Capin NR; Capin R; Zamacona G; Ortiz-Ortiz L
    Arch Invest Med (Mex); 1978; 9 Suppl 1():291-6. PubMed ID: 211963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to lysis by human serum of pathogenic Entamoeba histolytica.
    Reed SL; Sargeaunt PG; Braude AI
    Trans R Soc Trop Med Hyg; 1983; 77(2):248-53. PubMed ID: 6306876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of a virulence factor of Entamoeba histolytica. Pathogenic strains possess a unique cysteine proteinase gene.
    Reed S; Bouvier J; Pollack AS; Engel JC; Brown M; Hirata K; Que X; Eakin A; Hagblom P; Gillin F
    J Clin Invest; 1993 Apr; 91(4):1532-40. PubMed ID: 8473498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A surface amebic cysteine proteinase inactivates interleukin-18.
    Que X; Kim SH; Sajid M; Eckmann L; Dinarello CA; McKerrow JH; Reed SL
    Infect Immun; 2003 Mar; 71(3):1274-80. PubMed ID: 12595442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cysteine proteinase of Entamoeba histolytica in target cell death.
    Singh D; Naik SR; Naik S
    Parasitology; 2004 Aug; 129(Pt 2):127-35. PubMed ID: 15376772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.